» Articles » PMID: 37546583

Preferability of Molnupiravir, an Anti-COVID-19 Drug, Toward Purine Nucleosides: A Quantum Mechanical Study

Abstract

Structural aspects of molnupiravir complexed with the RNA of the SARS-CoV-2 virus have been recently resolved inside the RNA-dependent RNA polymerase (RdRp), demonstrating the interactions of molnupiravir with purine nucleosides. However, the preference of molnupiravir to interact with one purine nucleoside over another has not been clearly investigated. Herein, the complexation of molnupiravir in its active form with guanosine and adenosine was compared, using sundry density functional theory calculations. The plausible tautomeric structures of the molnupiravir drug in complex with guanosine/adenosine were minutely scrutinized. The relative energy findings outlined the favorability of amino-molnupiravir···keto-amino-guanosine and imino-molnupiravir···amino-adenosine optimized complexes. According to the interaction () and binding () energy values, higher preferential base-pairing of molnupiravir with guanosine over the adenosine one was recognized with / values of -31.16/-21.81 and -13.93/-12.83 kcal/mol, respectively. This could be interpreted by the presence of three and two hydrogen bonds within the former and latter complexes, respectively. Observable changes in the electronic properties and global indices of reactivity of the studied complexes also confirmed the preferential binding within the studied complexes. The findings from the quantum theory of atoms in molecules and the noncovalent interaction index also support the partially covalent nature of the investigated interactions. For both complexes, changes in thermodynamic parameters outlined the spontaneous, exothermic, and nonrandom states of the inspected interactions. Inspecting the solvent effect on the studied interactions outlined more observable amelioration within the water medium compared with the gas one. These results would be a durable ground for the forthcoming studies concerned with the interactions of the molnupiravir drug with purine nucleosides.

Citing Articles

On the Versatility of the -, -, and -Hybridized Chalcogen-Bearing Molecules To Engage in Type I Chalcogen···Chalcogen Interactions: A Quantum Mechanical Investigation of Like···Like and Unlike Complexes.

Ibrahim M, Saeed R, Shehata M, Moussa N, Soliman M, Khan S ACS Omega. 2024; 9(44):44448-44456.

PMID: 39524661 PMC: 11541515. DOI: 10.1021/acsomega.4c05963.


Small Molecule Drugs Targeting Viral Polymerases.

Palazzotti D, Sguilla M, Manfroni G, Cecchetti V, Astolfi A, Letizia Barreca M Pharmaceuticals (Basel). 2024; 17(5).

PMID: 38794231 PMC: 11124969. DOI: 10.3390/ph17050661.


σ-Hole Site-Based Interactions within Hypervalent Pnicogen, Halogen, and Aerogen-Bearing Molecules with Lewis Bases: A Comparative Study.

Ibrahim M, Mahmoud A, Shehata M, Saeed R, Moussa N, Sayed S ACS Omega. 2024; 9(9):10391-10399.

PMID: 38463322 PMC: 10918780. DOI: 10.1021/acsomega.3c08178.

References
1.
Humphrey W, Dalke A, Schulten K . VMD: visual molecular dynamics. J Mol Graph. 1996; 14(1):33-8, 27-8. DOI: 10.1016/0263-7855(96)00018-5. View

2.
Sharov A, Burkhanova T, Taskin Tok T, Babashkina M, Safin D . Computational Analysis of Molnupiravir. Int J Mol Sci. 2022; 23(3). PMC: 8835990. DOI: 10.3390/ijms23031508. View

3.
Hohenstein E, Parrish R, Sherrill C, Turney J, Schaefer 3rd H . Large-scale symmetry-adapted perturbation theory computations via density fitting and Laplace transformation techniques: investigating the fundamental forces of DNA-intercalator interactions. J Chem Phys. 2011; 135(17):174107. DOI: 10.1063/1.3656681. View

4.
Lu T, Chen F . Multiwfn: a multifunctional wavefunction analyzer. J Comput Chem. 2011; 33(5):580-92. DOI: 10.1002/jcc.22885. View

5.
Sheahan T, Sims A, Zhou S, Graham R, Pruijssers A, Agostini M . An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Sci Transl Med. 2020; 12(541). PMC: 7164393. DOI: 10.1126/scitranslmed.abb5883. View